Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Efficacy of Isatuximab-based Regimens in Relapsed/Refractory Multiple Myeloma With 1q21+
This clinical trial update shows recruiting status for regimens including isatuximab to treat relapsed/refractory multiple myeloma with 1q21…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Study on the Clinical Efficacy of Teclistamab
This clinical trial update notes that Teclistamab is currently recruiting to study its clinical efficacy in multiple myeloma and other hemat…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Blood Samples to Identify Biomarkers of Busulfan
A terminated clinical trial at Fred Hutchinson Cancer Center investigated using blood samples to identify biomarkers of busulfan exposure. T…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: The Norwegian Immunotherapy in Multiple Myeloma Study
The Norwegian immunotherapy in multiple myeloma study (NCT06855121) is currently recruiting. It targets multiple myeloma, plasma cell leukem…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: A "Physician & Patient-powered" Cohort Registry (MY MYELOMA)
This clinical trial update describes a physician- and patient-powered cohort registry for multiple myeloma that is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: Cost-utility Analysis of Ambulatory Dose Escalation of Bispecific Antibodies in Multiple Myeloma.
This clinical trial entry reports a cost-utility analysis plan for ambulatory dose escalation of bispecific antibodies in relapsed multiple …
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL) [Phase 3]
Phase 3 trial IsKia TRIAL compares isatuximab plus KRd (Isa-KRd) to KRd alone in newly diagnosed multiple myeloma patients eligible for auto…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients [Phase 2]
Phase 2 trial evaluating iberdomide (CC-220) as maintenance therapy after autologous stem cell transplant in newly diagnosed multiple myelom…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease [Phase 1, Phase 2]
This clinical trial update covers a BCMA-targeted CAR-T cell therapy being explored for relapsed/refractory multiple myeloma and plasma cell…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease [Phase 1, Phase 2]
A BCMA-targeted Prime CAR-T cell therapy is being evaluated for relapsed/refractory multiple myeloma and plasma cell neoplasms in Phase 1/2 …
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: A Trial for Relapsed Multiple Myeloma Patients (Isatuximab-dexamethasone) [Phase 2]
This document reports a Phase 2 clinical trial of isatuximab with dexamethasone for relapsed multiple myeloma. The study is currently active…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Rehabilitation Management for Patients with Multiple Myeloma
The document notes the completion of a clinical trial studying rehabilitation management for patients with multiple myeloma.
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project
This clinical trial update describes the PRO SID Project, which aims to develop and validate a patient-reported outcome screening measure fo…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Bioequivalence Studies of Dasatinib 100 Mg [Phase 4]
Phase 4 bioequivalence study of dasatinib 100 mg for multiple myeloma is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: A Study of ESO-T01 in Treating Relapsed/ Refractory Multiple Myeloma [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating ESO-T01 for relapsed or refractory multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Telehealth-based Symptom Management for Veterans Treated With Selinexor
ClinicalTrials.gov update indicates a telehealth-based symptom management study for veterans treated with selinexor is currently active but …
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer [NA]
A clinical trial is being developed to test an intervention that combines hypnosis and virtual reality to support patients with hematologic …
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine [Phase 1]
Phase 1 clinical trial update for an orally administered Salmonella-based survivin vaccine in multiple myeloma. The study status is listed a…
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Pre-approval Single-patient Expanded Access for Elranatamab (PF-06863135)
Pre-approval single-patient expanded access update for Elranatamab (PF-06863135) in multiple myeloma.
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients With Relapsed/Refractory Multiple Myeloma [Phase 2]
An open-label Phase 2 clinical study assessing the efficacy and safety of BCD-248 in adults with relapsed/refractory multiple myeloma; curre…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: A Phase Ib/II Clinical Study on the Application of Linperlisib Combined with the VRD Regimen in Newly Diagnosed Patients with Multiple Myeloma [Phase 1, Phase 2]
This update describes a Phase Ib/II study evaluating linperlisib in combination with the VRD regimen for newly diagnosed multiple myeloma, w…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors [NA]
A Clinical Trial Update describes a novel CAR-T therapy expressing IL-15 for malignant hematological tumors, with recruitment ongoing and no…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma
This completed clinical trial update summarizes an assessment of financial difficulty experienced by participants with chronic lymphocytic l…
-
CLINICAL_TRIALS research · 2025-01-16Clinical Trial Update: Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma [Phase 2]
This update describes a Phase 2 clinical trial evaluating selinexor in combination with DRd (daratumumab, lenalidomide, dexamethasone) for n…
-
CLINICAL_TRIALS research · 2025-01-16Clinical Trial Update: A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating venetoclax in combination with isatuximab and dexamethasone for relapsed/refractory multiple myeloma is …